These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7807907)

  • 21. [Enhanced activity of the protective factors in patients with suppurative surgical infection using interferon preparations].
    Karlov VA; Belotskiĭ SM; Filiukova OB; Zueva VS; Solov'ev VD
    Antibiot Med Biotekhnol; 1985 Oct; 30(10):770-3. PubMed ID: 3879158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Leukinferon in combined therapy for acute pulmonary tuberculosis].
    Erokhin VV; Mishin VIu; Makiev VG; Dryga OP; Gedymin LE; Lepekha LN; Beliaev DL; Babaiants AA
    Probl Tuberk Bolezn Legk; 2004; (10):10-5. PubMed ID: 15568311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of leukinferon on the invasive process in experimental helminthiases].
    Malysheva NS; Shuĭkina EE; Lebedeva MN; Fedianina LV
    Med Parazitol (Mosk); 1998; (1):17-20. PubMed ID: 9608203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of interferon preparations on the course of Salmonella infection (experimental and clinical studies)].
    Spivak NIa; Fil'chakov IV; Treshchinskiĭ AI; Kuznetsov VP; Zaritskiĭ AM; Belotskiĭ SM
    Antibiot Khimioter; 1992 Mar; 37(3):28-31. PubMed ID: 1514865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of indomethacin and leukinferon on the thromboxane B2 level in the blood plasma of patients with endometrial cancer in the perioperative period].
    Bassalyk LS; Shoshiashvili VD; Kushlinskiĭ NE; Mistakopulo NF; Kuznetsov VP; Rylov VV; Liakina LT
    Vopr Onkol; 1992; 38(5):555-61. PubMed ID: 1300754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic antiradiation properties of leukinferon].
    Ivanov AA; Kuznetsov VP; Ulanova AM; Stavrakova NM; Kuz'mina TD; Leonenko IV; Gutsenko KK; Shal'nova GA; Beliaev DL; Babaiants AA
    Radiats Biol Radioecol; 1998; 38(1):62-70. PubMed ID: 9606407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of treatment on the course of invasion by Hymenolepis nana and the state of its population in white mice].
    Malysheva NS
    Med Parazitol (Mosk); 1998; (2):46-8. PubMed ID: 9691622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of immunomodulator leukinferon on the course of experimental tuberculosis].
    Gedymin LE; Erokhin VV; Lepekha LN; Nikolaeva GM; Kaminskaia GO; Kuznetsov VP; Beliaev DL; Babaiants AA
    Probl Tuberk; 2003; (1):45-52. PubMed ID: 12652986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of the abnormal tracheobroncheal tree in the efficiency of treatment of patients with pulmonary tuberculosis].
    Maliev BM; Gracheva MP; Beliaev DL; Gabaraev AS
    Probl Tuberk Bolezn Legk; 2007; (8):19-25. PubMed ID: 17915462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The use of leukinferon in treating measles in adult patients].
    Nikolaeva IN; Kuznetsov VP; Barer GM; Parkhomenko IuG; Beliaev DL; Sinitsyna OV; Babaiants AA; Iushchuk ND
    Stomatologiia (Mosk); 1995; 74(3):32-5. PubMed ID: 7570694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunomodulating properties of leukinferon].
    Iushchuk ND; Zmyzgova AV; Tugutova IV; Kuznetsov VP; Babaiants AA; Novikova TA; Eremina OF; Mesniankin AP; Lebedev VV; V'iushina MA
    Sov Med; 1990; (7):11-4. PubMed ID: 2251550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and differentiated treatment of secondary immunodeficiencies].
    Kolesnikov AP; Khabarov AS; Kozlov VA
    Ter Arkh; 2001; 73(4):55-9. PubMed ID: 11494450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Leukinferon in the combined therapy of infection in neonates and infants].
    Nizharadze GI; Kuznetsov VP; Gamkhitashvili ASh; Chitaishvili KG; Pavlenishvili IV
    Pediatriia; 1989; (6):46-9. PubMed ID: 2668867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in the immune status parameters and their correction in various forms of tick-borne encephalitis].
    Krylova NV; Iakusheva SS; Borisevich VG; Leonova GN
    Antibiot Khimioter; 2001; 46(7):23-6. PubMed ID: 11697240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Differentiated therapy of a general suppurative infection].
    Shaposhnikov IuG; Reshetnikov EA
    Sov Med; 1980; (5):28-31. PubMed ID: 7384895
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of immunomodulator derinat in the treatment of patients with surgical sepsis in traumatic shock].
    Gromov MI; Pivovarova LP
    Vestn Khir Im I I Grek; 2002; 161(6):45-8. PubMed ID: 12638492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of using T-activin in the therapy of the newborn with suppurative surgical infection.
    Samsygin SA; Dolgina EN; Arion VYa ; Romanova LA; Shchevochkina GI; Ovchinnikova EA
    J Hyg Epidemiol Microbiol Immunol; 1989; 33(3):269-76. PubMed ID: 2809182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of leukinferon on the activity of phagocytosing cells in human salmonellosis].
    Zueva VS; Spivak NIa; Fil'chakov IV; Kuznetsov VP; Bratus' EV
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Sep; (9):21-5. PubMed ID: 1759515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tumor necrosis factor and possibilities of correction of its production in patients with suppurative-septic complications in terminal states].
    Leshin AA; Pisarev VM; Kremlev SG; Tutel'ian AV; Lebedev VV
    Anesteziol Reanimatol; 1993; (2):38-40. PubMed ID: 7943878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The clinical efficacy in using leukinferon in adults with diseases caused by the varicella-zoster virus].
    Kuznetsov VP; Nikolaeva IN; Barer GM; Beliaev DL; Sundukov AV; Babaiants AA; Iushchuk ND
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (4):72-5. PubMed ID: 9381878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.